Kurt R. Zinn is a professor in the Department of Biomedical Engineering and conducts research in the field of molecular imaging, including as part of cancer diagnosis and therapy and neuroimaging of drug delivery to the brain.
With experience in more than 10 Phase 1 clinical trials, he expects to conduct clinical trials in both veterinary and human medicine and use radionuclides that will be available from FRIB.
Prior to joining MSU, Dr. Zinn held a number of roles at University of Alabama including professor of radiology, director of UAB’s Laboratory of Multimodality Imaging and Small Animal Imaging Shared Facility, director of Radiology’s Division of Advanced Medical Imaging Research, and vice-chair of Translational research.
Dr. Zinn received the Distinguished Investigator Award from the Academy of Radiology Research in 2015. He holds a B.A. in chemistry, a DVM in veterinary medicine, an M.S. in chemistry, and a Ph.D. in biochemistry, all from the University of Missouri-Columbia.